


Multi-antigen Vaccination With Simultaneous Engagement of the OX40 Receptor Delays Malignant Mesothelioma Growth and Increases Survival in Animal Models
Multi-antigen Vaccination With Simultaneous Engagement of the OX40 Receptor Delays Malignant Mesothelioma Growth and Increases Survival in Animal Models
Computational Identification of Self-Like Neoantigens Enables the Rapid Design of Immunogenic Cancer Vaccines
EpiVax_Oncology_TRI-CON_CT26_04Mar19_32w44h